AVR-AgDb: A Plant-Based Antiviral Repository to Minimize the Detrimental Effects of Frequent Viral Outbreaks and the Next Pandemic
129 / 125
Keywords:
Database, Virus; Viral diseases; Plant-based; Antiviral compounds; COVID-19; AVR-AgDb.Abstract
There is an imperative need to investigate less toxic antiviral phytomolecules than nucleic acid analogs, enzyme inhibitors, or synthetic molecules as
antiviral therapeutics. Agricultural crops and their secondary metabolites have been well known for their healing and immunity-boosting properties
throughout the globe since human civilization. A recent global pandemic, COVID-19, caused by Severe Acute Respiratory Syndrome Coronavirus 2
(SARS-CoV-2), has become one of the most devastating challenges for humans, compounded by increasing diffusion due to migration, global travel,
and urbanization. Even before this, about >650K annual deaths had been due to seasonal viral flu disease alone. Dramatic mutations in viruses and the
time needed in vaccine development have made the world realize nutrition-immunity intervention as a pragmatic preventive approach for most human
viral diseases. In the telecommunications era, an efficient, user-friendly database for searching antiviral plants and their constituents is a prerequisite.
Such a database will also facilitate post-COVID economic resilience in the agricultural system. It may also accelerate the research and development
of eco-friendly antiviral molecules from natural resources. It further provides classified antiviral molecules with their specific names and structure,
their modes of action, and model organisms studied, along with respective literature references. This information can be accessed or retrieved plant
wise, viral disease-wise and chemical compound class/sub-class-wise using a URL (https://avragdb.abrl.in/). It comprehensively comprehends about
>350 molecules with antiviral properties from >500 plants of medicinal and agricultural importance. The database could be useful for phytotherapy
research and spreading the accountability of plant-based antiviral formulations.
Downloads
References
1. Adhikari B, Marasini BP, Rayamajhee B, Bhattarai BR, Lamichhane
2. G, Khadayat K, Adhikari A, Khanal S, Parajuli N (2021) Potential
3. roles of medicinal plants for the treatment of viral diseases
4. focusing on COVID‐19: A review. Phytotherapy Research 35,
5. 1298-1312
6. Adeosun, W.B. and Loots, D.T., 2024. Medicinal Plants against Viral
7. Infections: A Review of Metabolomics Evidence for the Antiviral
8. Properties and Potentials in Plant Sources. Viruses, 16(2), p.218.
9. Abookleesh FL, Al-Anzi BS, Ullah A (2022) Potential Antiviral Action
10. of Alkaloids. Molecules, 27, 903
11. Abou Baker DH, Amarowicz R, Kandeil A, Ali MA, Ibrahim EA
12. (2021) Antiviral activity of Lavandulaangustifolia L. and Salvia
13. officinalis L. essential oils against avian influenza H5N1 virus.
14. Journal of Agriculture and Food Research, 4, 100135.
15. Adamson CS, Chibale K, Goss RJ, Jaspars M, Newman DJ, Dorrington
16. RA (2021) Antiviral drug discovery: Preparing for the next
17. pandemic. Chemical Society Reviews, 50, 3647-3655
18. Aher RB and Sarkar D (2021) Online Tools and Antiviral Databases
19. for the Development of Drugs against Coronaviruses. In Silico
20. Modeling of Drugs against Coronaviruses (717-734). Humana,
21. New York, NY.
22. Ahmed MN, Jahan R, Nissapatorn V, Wilairatana P Rahmatullah M
23. (2022) Plant lectins as prospective antiviral biomolecules in the
24. search for COVID-19 eradication strategies. Biomedicine &
25. Pharmacotherapy, 146, 112507.
26. Al-Beltagi S, Goulding LV, Chang DK, Mellits KH, Hayes CJ,
27. Gershkovich P (2021) Emergent SARS-CoV-2 variants:
28. comparative replication dynamics and high sensitivity to
29. thapsigargin. Virulence, 12, 2946-2956.
30. 172
31. Tilak Chandra et al. / Journal of the Indian Society of Agricultural Statistics 165–174
32. Al-Hawari F, Etaiwi H, Alouneh S (2017) A cost-effective information
33. display system based on open-source technologies. In 2017
34. International Conference on New Trends in Computing Sciences
35. (ICTCS) (277-282). IEEE.
36. Alhazmi HA, Najmi A, Javed SA, Sultana S, Al Bratty M,
37. Makeen HA (2021) Medicinal plants and isolated molecules
38. demonstrating immunomodulation activity as potential alternative
39. therapies for viral diseases including COVID-19. Frontiers in
40. Immunology.1721.
41. Ali SI, Sheikh WM, Rather MA, Venkatesalu V, Muzamil Bashir S,
42. Nabi SU (2021) Medicinal plants: Treasure for antiviral drug
43. discovery. Phytotherapy Research, 35, 3447-3483.
44. Amoros M, BFauconnier, RL Girre (1987) In vitro antiviral activity
45. of a saponin from Anagallisarvensis, Primulaceae, against herpes
46. simplex virus and poliovirus. Antiviral Res. 8, 13-25
47. Baboonian C, Davies MJ, Booth JC, McKenna WJ (1997) Coxsackie B
48. viruses and human heart disease. The coxsackie B viruses. 31-52.
49. Bachar SC, Mazumder K, Bachar R, Aktar A, Al Mahtab M (2021)
50. A review of medicinal plants with antiviral activity available in
51. Bangladesh and mechanistic insight into their bioactive metabolites
52. on SARS-CoV-2, HIV and HBV. Frontiers in Pharmacology, 12.
53. Badaczewska-Dawid AE, Kolinski A, Kmiecik S (2020) Protocols
54. for fast simulations of protein structure flexibility using CABS
55. Flex and SURPASS. In Protein Structure Prediction (337-353).
56. Humana, New York, NY.
57. Banerjee P, Eckert AO, Schrey AK, Preissner R (2018) ProTox-II: a
58. webserver for the prediction of toxicity of chemicals. Nucleic
59. acids research, 46, 257-263
60. Ben-Shabat S, Yarmolinsky L, Porat D, Dahan A (2020) Antiviral effect
61. of phytochemicals from medicinal plants: Applications and drug
62. delivery strategies. Drug delivery and translational research, 10,
63. 354-367.
64. Budhwar S, Sethi K, Chakraborty M (2020) A rapid advice guideline
65. for the prevention of novel coronavirus through nutritional
66. intervention. Current Nutrition Reports, 9, 119-128.
67. Cavanagh HMA and Wilkinson JM (2002) Biological activities of
68. lavender essential oil. Phytotherapy research, 16, 301-308
69. Cherrak SA, Merzouk H, Mokhtari-Soulimane N (2020) Potential
70. bioactive glycosylated flavonoids as SARS-CoV-2 main protease
71. inhibitors: A molecular docking and simulation studies. PLoS
72. One, 15, e0240653.
73. Coulibaly F (2021) virusMED: your travel guide to the virus world.
74. IUCrJ, 8, 857
75. COVID-19 Dashboard by the Center for Systems Science and
76. Engineering (CSSE) at Johns Hopkins University (JHU)”.
77. ArcGIS. Johns Hopkins University. Retrieved 28 November 2022.
78. Cryer M, Lane K, Greer M, Cates R, Burt S, Andrus M (2017) Isolation
79. and identification of compounds from Kalanchoepinnata having
80. human alphaherpesvirus and vaccinia virus antiviral activity.
81. Pharmaceutical biology, 55, 1586-1591
82. Denyer CV, Jackson P, Loakes DM, Ellis MR, Young DA (1994) Isolation
83. of antirhinoviralsesquiterpenes from ginger (Zingiberofficinale).
84. Journal of natural products, 57, 658-662
85. Do TV, Krieger UR, Chakka R (2008) Performance modeling of an
86. apache web server with a dynamic pool of service processes.
87. Telecommunication Systems, 39, 117-129
88. Douek DC, Roederer M, Koup RA (2009). Emerging concepts in the
89. immunopathogenesis of AIDS. Annual review of medicine, 60,
90. 471
91. Endy and Nisalak (2002). Japanese encephalitis virus: ecology and
92. epidemiology. Japanese encephalitis and West Nile viruses.11, 48
93. Fidanka T (2021) Herbs & spices, sub-sector analysis Socio-economic
94. impact of the COVID-19 crisis in the agriculture.
95. Fu Y, Jaarsma AH, Kuipers OP (2021). Antiviral activities and
96. applications of ribosomally synthesized and post-translationally
97. modified peptides (RiPPs). Cellular and molecular life sciences,
98. 78, 3921-3940
99. Gad EAM, AhmedME, Al-Fahemi JH (2021) Comparative study on
100. quantum descriptors, molecular docking and dynamic simulation
101. of antiviral drugs with Covid-19. Egyptian Journal of Petroleum,
102. 30, 45-51
103. Gangal N, Nagle V, Pawar Y, Dasgupta S (2020) Reconsidering
104. traditional medicinal plants to combat COVID-19. AIJR Preprints,
105. 34, 1-6
106. Ghildiyal R, Prakash V, Chaudhary VK, Gupta V, Gabrani R (2020)
107. Phytochemicals as antiviral agents: recent updates. In Plant
108. derived bioactives (279-295). Springer, Singapore.
109. Goyal S and Gill A (2021) Deploying a framework to improve the
110. performance of a web service. Technology (IJEET), 12, 137-147
111. Griffin DE, Lin WH, Pan CH (2012) Measles virus, immune control,
112. and persistence. FEMS microbiology reviews, 36, 649-662
113. Griffiths C, Drews SJ, Marchant DJ (2017). Respiratory syncytial virus:
114. infection, detection, and new options for prevention and treatment.
115. Clinical microbiology reviews, 30, 277-319
116. Gupta S, Singh AK, Kushwaha PP, Prajapati KS, Shuaib M, Senapati
117. S (2021). Identification of potential natural inhibitors of SARS
118. CoV2 main protease by molecular docking and simulation studies.
119. Journal of Biomolecular Structure and Dynamics, 39, 4334-4345.
120. Hamulka J, Jeruszka-Bielak M, Górnicka M, Drywień ME, Zielinska
121. Pukos MA (2021). Dietary supplements during COVID-19
122. outbreak. Results of google trends analysis supported by
123. PLifeCOVID-19 online studies. Nutrients, 13, 54
124. Horvath G and Acs K (2015) Essential oils in the treatment of respiratory
125. tract diseases highlighting their role in bacterial infections and
126. their anti‐inflammatory action: a review. Flavourand Fragrance
127. Journal, 30, 331-341
128. Hospital A, Goni JR, Orozco M, Gelpi JL (2015) Molecular dynamics
129. simulations: advances and applications. Advances and applications
130. in bioinformatics and chemistry: AABC, 8, 37
131. Hu B, Guo H, Zhou P, Shi ZL (2021) Characteristics of SARS-CoV-2
132. and COVID-19. Nature Reviews Microbiology, 19, 141-154
133. Iquebal MA, Jaiswal S, Mahato AK, Jayaswal PK, Angadi UB, Kumar
134. N (2017) MiSNPDb: a web-based genomic resources of tropical
135. ecology fruit mango (Mangiferaindica L.) for phylogeography and
136. varietal differentiation. Scientific Reports, 7, 1-9
137. Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ (2008)
138. Cyclotides as natural anti‐HIV agents. Peptide Science, 90, 51-60
139. Kamboj A, Saluja AK, Kumar M, Atri P (2012). Antiviral activity of
140. plant polyphenols. J. Pharm. Res, 5, 2402-2412
141. Khaerunnisa S, Kurniawan H, Awaluddin R, Suhartati S, Soetjipto S
142. (2020). Potential inhibitor of COVID-19 main protease (Mpro)
143. Tilak Chandra et al. / Journal of the Indian Society of Agricultural Statistics 165–174
144. from several medicinal plant compounds by molecular docking
145. study. Preprints, 2020, 2020030226.
146. 173
147. Piret J and Boivin G (2021) Pandemics throughout history. Frontiers in
148. microbiology, 11, 631736
149. Khuntia BK, Sharma V, Wadhawan M, Chhabra V, Kidambi B, Rathore
150. S (2022) Antiviral potential of Indian medicinal plants against
151. influenza and SARS-CoV: a systematic review. Natural Product
152. Communications, 17, 1934578X221086988
153. Koonin EV, Senkevich TG, Dolja VV (2006). The ancient Virus World
154. and evolution of cells. Biology direct, 1, 1-27
155. Kudi AC, Myint SH (1999) Antiviral activity of some Nigerian
156. medicinal plant extracts. Journal of ethnopharmacology, 68,
157. 289-294
158. Kuriata A, Gierut AM, Oleniecki T, Ciemny MP, Kolinski A, Kurcinski
159. M (2018) CABS-flex 2.0: a web server for fast simulations
160. of flexibility of protein structures. Nucleic acids research, 46,
161. 338-343
162. Kurokawa M, Basnet P, Ohsugi M, Hozumi T, Kadota S, Namba T
163. (1999) Anti-Herpes Simplex Virus Activity of Moronic Acid
164. Purified fromRhusjavanica In Vitro and In Vivo. Journal of
165. Pharmacology and Experimental Therapeutics, 289, 72-78
166. Lipinski CA (2004) Lead-and drug-like compounds: the rule-of-five
167. revolution. Drug discovery today: Technologies, 1, 337-341
168. Liu X, Zhang B, Wang Y, Haymour HS, Zhang F, Xu LC (2020) A
169. universal dual mechanism immunotherapy for the treatment of
170. influenza virus infections. Nature communications, 11, 1-14
171. Malgwi YM, Mathias L, Muhammad LJ (2018) Development and
172. implementation of e-commerce system. International Journal of
173. Advanced Research in Computer Science, 9, 1
174. Mammari N, Krier Y, Albert Q, Devocelle M, Varbanov M, Oemonom
175. (2021) Plant-Derived Antimicrobial Peptides as Potential Antiviral
176. Agents in Systemic Viral Infections. Pharmaceuticals, 14, 774
177. Maximiano MR and Franco OL (2021) Biotechnological applications
178. of versatile plant lipid transfer proteins (LTPs). Peptides, 140,
179. 170531
180. Mukherjee S, ChouhanKBS, Tandey R, Yadav N, Dhobi M, Mandal V
181. (2021) A status report with critical analysis of research trends in
182. exploring medicinal plants as antiviral: Let us dig into the history
183. to predict the future. Phytotherapy Research, 35, 4284-4296
184. Mukhtar M, Arshad M, Ahmad M, Pomerantz RJ, Wigdahl B, Parveen
185. Z (2008) Antiviral potentials of medicinal plants. Virus research,
186. 131, 111-120
187. Pandur E, Balatinácz A, Micalizzi G, Mondello L, Horváth
188. A, Sipos K (2021) Anti-inflammatory effect of lavender
189. (Lavandulaangustifolia Mill.) essential oil prepared during
190. different plant phenophases on THP-1 macrophages. BMC
191. complementary medicine and therapies, 21, 1-17
192. Pastor N, Collado MC, Manzoni P (2021) Phytonutrient and nutraceutical
193. action against COVID-19: current review of characteristics and
194. benefits. Nutrients, 13:464
195. Patel B, Sharma S, Nair N, Majeed J, Goyal RK, Dhobi M (2021)
196. Therapeutic opportunities of edible antiviral plants for COVID-19.
197. Molecular and Cellular Biochemistry, 476, 2345-2364
198. Perez RM (2003). Antiviral activity of compounds isolated from plants.
199. Pharmaceutical biology, 41, 107-157
200. Phumesin P, Panaampon J, Kariya R, Limjindaporn T, Yenchitsomanus
201. PT,Okada S (2022) Cepharanthine Inhibits Dengue Virus
202. Production and Cytokine Secretion. Virus Research.199030
203. Quadros de Azevedo, D., ViníciusVieraNóia, J., Ribeiro, Y.C.M., Alves
204. dos Reis, R., Ribeiro, P.H.O., Almeida Moura, G., Mendes, P.,
205. Barbosa de Souza, A.B., CarpiniMermejo, S., Serafim, M.S.M. and
206. Fernandes, T.H.M., 2024. Development of an Antiviral Medicinal
207. Plant and Natural Product Database (avMpNp Database) from
208. Biodiversity. Chemistry & Biodiversity, 21(12), p.e202400285.
209. Quer J, Rodríguez-Frias F, Gregori J, TaberneroD, SoriaME, García
210. Cehic D (2017) Deep sequencing in the management of hepatitis
211. virus infections. Virus research, 239, 115-125
212. Qureshi A, Thakur N, Tandon H, Kumar M (2014) AVPdb: a database
213. of experimentally validated antiviral peptides targeting medically
214. important viruses. Nucleic acids research, 42, 1147-1153.
215. Racaniello VR (2006) One hundred years of poliovirus pathogenesis.
216. Virology, 344, 9-16
217. Raven PH (2019) Saving plants, saving ourselves. Plants, People,
218. Planet, 1, 8-13
219. Rizvi SMD, Shakil S, Haneef M (2013) A simple click by click
220. protocol to perform docking: AutoDock 4.2 made easy for non
221. bioinformaticians. EXCLI journal, 12, 831
222. Rolland JS (2020) COVID‐19 pandemic: Applying a multisystemic
223. lens. Family process, 59, 922-936
224. Sabbaghi A, Miri SM, Keshavarz M, Zargar M, Ghaemi A (2019)
225. Inactivation methods for whole influenza vaccine production.
226. Reviews in medical virology, 29, e2074
227. Salmerón-Manzano E, Garrido-Cardenas JA, Manzano-Agugliaro
228. F (2020) Worldwide research trends on medicinal plants.
229. International journal of environmental research and public health,
230. 17, 3376
231. Sellers MS and Hurley MM (2016) XPairIt Docking Protocol for
232. peptide docking and analysis. Molecular Simulation, 42, 149-161
233. Sharma N, Murali A, Singh SK, Giri R (2017). Epigallocatechin gallate,
234. an active green tea compound inhibits the Zika virus entry into
235. host cells via binding the envelope protein. International journal
236. of biological macromolecules, 104, 1046-1054
237. Singh NA, Kumar P, Kumar N (2021) Spices and herbs: potential
238. antiviral preventives and immunity boosters during COVID‐19.
239. Phytotherapy Research, 35, 2745-2757
240. Sultan MT, Buttxs MS, Qayyum MMN, Suleria HAR (2014) Immunity:
241. plants as effective mediators. Critical reviews in food science and
242. nutrition, 54, 1298-1308.
243. Thomas E, Stewart LE, Darley BA, Pham AM, Esteban I, Panda SS
244. (2021) Plant-Based Natural Products and Extracts: Potential
245. Source to Develop New Antiviral Drug Candidates. Molecules.
246. 26, 6197
247. Trivedi P, Abbas A, Lehmann C, Rupasinghe HV (2022) Antiviral
248. and Anti-Inflammatory Plant-Derived Bioactive Compounds
249. and Their Potential Use in the Treatment of COVID-19-Related
250. Pathologies. Journal of Xenobiotics, 12, 289-306
251. Ullah, S., Rahman, W., Ullah, F., Ullah, A., Ahmad, G., Ijaz, M., Ullah,
252. H., Zheng, Z. and Gao, T., 2023. AVPCD: a plant-derived medicine
253. database of antiviral phytochemicals for cancer, Covid-19, malaria
254. and HIV. Database, 2023, p.baad056.
255. Virus Taxonomy: (2021) Release”. International Committee on
256. Taxonomy of Viruses. Retrieved 4 April 2022.
257. 174
258. Tilak Chandra et al. / Journal of the Indian Society of Agricultural Statistics 165–174
259. Walia ES and Gill ESK (2014) A framework for web based student
260. record management system using PHP. International Journal of
261. Computer Science and Mobile Computing, 3, 24-33
262. Wen CC, Kuo YH, Jan JT, Liang PH, Wang SY, Liu HG (2007) Specific
263. plant terpenoids and lignoids possess potent antiviral activities
264. against severe acute respiratory syndrome coronavirus. Journal of
265. medicinal chemistry, 50, 4087-4095
266. Whitley RJ and Roizman B (2001). Herpes simplex virus infections.
267. The lancet, 357, 1513-1518
268. Xu XY, Wang DY, Li YP, Deyrup ST, Zhang HJ (2021) Plant-derived
269. lignans as potential antiviral agents: A systematic review.
270. Phytochemistry Reviews.1-51
271. Yang A, Wu J, Wang L (2008) Research and design of test question
272. database management system based on the three-tier structure.
273. WTOS, 7, 1473-1483.
274. Yang Y, Xiu J, Zhang L, Qin C, Liu J (2012) Antiviral activity of
275. punicalagin toward human enterovirus 71 in vitro and in vivo.
276. Phytomedicine, 20, 67-70
277. Yuce M, Cicek E, Inan T, Dag AB, Kurkcuoglu O, Sungur FA (2021)
278. Repurposing of FDA‐approved drugs against active site and
279. potential allosteric drug‐binding sites of COVID‐19 main protease.
280. Proteins: Structure, Function, and Bioinformatics, 89, 1425-1441
281. Fig. 1 A web resource, AVR-AgDb: A plant-based antiviral repository was
282. created using the three-tier architecture viz. client, middle, and database
283. tier to contain all the collective and compiled results on plant-based
284. antiviral molecules, their characteristic features. XAMPP framework was
285. used to design and deploy the webpage. The website framework was made
286. using HTML, designing was done by using CSS, and was made dynamic
287. using JavaScript, while software Apache was used as the web server, the
288. website was supported by the MySQL database in the backend, and PHP
289. was used as the server-side language and for database connectivity.
290. Fig. 2. The cartoon diagram summarizes that medicinal agricultural crops
291. produce three kinds of phyto-compounds. These are phytonutrients,
292. nutraceuticals, and phytochemicals. These plants’ derivative antiviral
293. compounds are used as preventive antiviral measures or utilized post
294. viral infection. These compounds act directly on the virus life cycle or
295. boost host immunity in multifarious ways. A centrally developed database
296. collectively provides user-friendly access to known antiviral molecules,
297. their mode of action, and other necessary related information with a single
298. click. Bi-model search option makes it more effortless to find plant-based
299. antiviral molecules for the sixteen deadliest viruses. The virus and database
300. figures have been fetched from BioRender (https://biorender.com/)